Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents
Source abstract
Abstract
This work described a proof of concept study of hybrid nanogel-based magnetic resonance contrast agents, SPIO@GCS/acryl/biotin@Mn-gel, abb. as SGM, for highly efficient, pH-responsive T1 and T2 dual-mode magnetic resonance imaging (MRI). SGM have been synthesized by assembling superparamagnetic iron oxide particles into polysaccharide nanoclusters, followed by in-situ reduction of the manganese species on the clusters and a final mild polymerization. The dual-mode SGM showed an interesting pH-responsiveness in in vitro MRI, with both T1 and T2 relaxivities turned "ON" in the acidic environment, along with an increase in the r1 and r2 relaxivity values by 1.7-fold (from 8.9 to 15.3 mM(-1) S(-1)) and 4.9-fold (from 45.7 to 226 mM(-1) S(-1)), due to desirable silencing and de-silencing effects. This interesting acidic-responsiveness was further verified in vivo with both significantly brightened signal of tumor tissue in T1-weighted MR images and a darkened signal in T2-weighted MR images 50 min post-injection of SGM. This smart hybrid nanogel may serve as a promising candidate for further studies of dual-mode (T1 and T2) contrast agents in MRI, due to its high stability, interesting pH-response mechanism and indicative imaging of tumors.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Cancer nanotechnology: opportunities and challenges10.1038/nrc1566 ↗
2. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy10.1021/ar200044b ↗
3. Bioresponsive, cell-Penetrating, and multimeric MR contrast agents10.1021/ar800245h ↗
4. Challenges for molecular magnetic resonance imaging10.1021/cr100025t ↗
5. Magnetogenesis in water induced by a chemical analyte10.1002/anie.201305662 ↗
6. Self-confirming “AND” logic nanoparticles for fault-free MRI10.1021/ja104503g ↗
7. Inorganic nanoparticles for MRI contrast agents10.1002/adma.200802366 ↗
8. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology10.1021/ar800045c ↗
9. Multifunctional magnetic nanoparticles for targeted imaging and therapy10.1016/j.addr.2008.03.014 ↗
10. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications10.1021/ar9000026 ↗
11. Ultrasmall water-soluble and biocompatible magnetic iron oxide nanoparticles as positive and negative dual contrast agents10.1002/adfm.201103123 ↗
12. Manganese-loaded dual-mesoporous silica spheres for efficient T1- and T2-weighted dual mode magnetic resonance imaging10.1021/am401856w ↗
13. Improving T1 and T2 magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes10.1002/cmmi.483 ↗
14. A synergistically enhanced T1-T2 dual-modal contrast agent10.1002/adma.201203169 ↗
15. Soft nanotechnology with soft nanoparticles10.1002/anie.200501321 ↗
16. Nanogels as pharmaceutical carriers: finite networks of infinite capabilities10.1002/anie.200900441 ↗
17. Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications10.1002/tcr.201000008 ↗
18. The Development of microgels/nanogels for drug delivery applications10.1016/j.progpolymsci.2008.01.002 ↗
19. Advanced nanogel engineering for drug delivery10.1039/B811923F ↗
20. Smart inorganic/organic hybrid microgels: synthesis and characterisation10.1039/b820292n ↗
21. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines10.1038/nmat2784 ↗
22. Ultrahigh-water-content supramolecular hydrogels exhibiting multistimuli responsiveness10.1021/ja3044568 ↗
23. Self-delivery multifunctional anti-HIV hydrogels for sustained release10.1002/adhm.201300041 ↗
24. Chemically programmed self-Sorting of gelator networks
25. Foreword · 2012
26. Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents10.1002/anie.201203190 ↗
27. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles10.1021/ja0380852 ↗
28. Enzyme initiated radical polymerizations10.3390/polym4010759 ↗
29. Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations10.1002/nbm.945 ↗
30. Tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery10.1002/anie.200907210 ↗
31. MRI contrast agents: the next generation10.1071/CH02172 ↗
32. Magnetic nanobeads as potential contrast agents for magnetic resonance imaging10.1021/nn403647t ↗
33. Development of a T1 contrast agent for magnetic resonance imaging using Gd2O3 nanoparticles10.1007/978-3-642-03879-2_150 ↗
34. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery10.1002/anie.200802323 ↗
35. Urchin-shaped manganese oxide nanoparticles as pH-responsive activatable T1 contrast agents for magnetic resonance imaging10.1002/anie.201103108 ↗
36. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI10.1021/nn1019779 ↗
37. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells10.1016/j.biomaterials.2012.06.059 ↗
38. Fe3O4/MnO hybrid nanocrystals as a dual contrast agent for both T1- and T2-weighted liver MRI10.1016/j.biomaterials.2012.11.054 ↗
39. On T2-shortening by weakly magnetized particles: the chemical exchange model10.1002/mrm.1135 ↗
40. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity10.1021/nl102623x ↗
41. Enhanced magnetic resonance contrast of Fe3O4 nanoparticles trapped in a porous silicon nanoparticle host10.1002/adma.201101877 ↗
42. Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging10.1038/ncomms3266 ↗
43. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging10.1016/j.biomaterials.2009.02.001 ↗
44. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions10.1007/s00330-008-1172-x ↗